Search
for
Sort by
Research 361–390 of 1000+
- Bilateral ovarian steroid cell tumor in a postmenopausal woman with progressive hyperandrogenism
- Low-Dose Dimethyl Sulfoxide (DMSO) Suppresses Androgen Receptor (AR) and Its Splice Variant AR-V7 in Castration-Resistant Prostate Cancer (CRPC) Cells
- Postnatal determinants of testicular germ cell tumor by histological subtypes: The EPSAM1 and EPSAM2 studies
- Ovarian steroid cell tumor in a teenager masquerading as polycystic ovary syndrome: a case report and literature review
- Rare virilizing tumor: ovarian steroid cell tumor, not otherwise specified: a case report
- Toward a Diagnostic Score in Cushing's Syndrome
- Polycystic ovary syndrome and the differential diagnosis of hyperandrogenism
- Diagnosing polycystic ovary syndrome
- Melanoma: Genetic Abnormalities, Tumor Progression, Clonal Evolution and Tumor Initiating Cells
- Mouse Intestinal Krt15+ Crypt Cells Are Radio-Resistant and Tumor Initiating
- Cyclin D3 deficiency inhibits skin tumor development, but does not affect normal keratinocyte proliferation
- The stiffness of the extracellular matrix is a key factor in tumor progression
- Toll-like receptor-targeted anti-tumor therapies: Advances and challenges
- Volume imaging to interrogate cancer cell-tumor microenvironment interactions in space and time
- Activator Protein-1 Activity Regulates Epithelial Tumor Cell Identity
- Hyaluronic acid-FGF2-derived peptide bioconjugates for suppression of FGFR2 and AR simultaneously as an acne antagonist
- The relationship between keratin 18 and epithelial-derived tumors: as a diagnostic marker, prognostic marker, and its role in tumorigenesis
- CD4+CD25+FoxP3+ Regulatory Tregs inhibit fibrocyte recruitment and fibrosis via suppression of FGF-9 production in the TGF-β1 exposed murine lung
- Cutaneous Lymphadenoma Is a Distinct Trichoblastoma-like Lymphoepithelial Tumor With Diffuse Androgen Receptor Immunoreactivity, Notch1 Ligand in Reed-Sternberg–like Cells, and Common EGFR Somatic Mutations
- Expression of Potential Dermal Progenitor Cell Markers in the Tumour and Stroma of Skin Adnexal Malignant and Benign Tumours
- Astilbin Activates the Reactive Oxidative Species/PPARγ Pathway to Suppress Effector CD4+ T Cell Activities via Direct Binding With Cytochrome P450 1B1
- Green Nanodrugs: Research Progress and Challenges of Plant-Derived Nanovesicles in Tumor Treatment
- Idiopathic isolated adrenocorticotropic hormone deficiency combined with testicular germ cell tumor: Case report
- Potential of Natural Products in Hangeshashinto Water Extract on the Direct Suppression of Stomatitis Induced by Intra-/Extracellular Advanced Glycation End-Products
- Transcranial focused ultrasound-mediated unbinding of phenytoin from plasma proteins for suppression of chronic temporal lobe epilepsy in a rodent model
- Bioengineered polyester nanoparticles for the synergistic treatment of androgenic alopecia via the suppression of 5α-reductase and knockdown of androgen receptor
- Progeny of Lgr5-expressing hair follicle stem cell contributes to papillomavirus-induced tumor development in epidermis
- Recent Advances in Genome-Editing Technology with CRISPR/Cas9 Variants and Stimuli-Responsive Targeting Approaches within Tumor Cells: A Future Perspective of Cancer Management
- Oral Combination Treatment of Gefitinib (IressaTM) and Sasam-Kyeongokgo: Synergistic Effects on the NCI-H520 Tumor Cell Line
- Large Screening Identifies ACE2 Positively Correlates With NF-κB Signaling Activity and Targeting NF-κB Signaling Drugs Suppress ACE2 Levels